Table 3 Association between baseline TyG and incident heart failure in the Kailuan cohort

Number of patients

23,997

24,000

24,001

23,998

HF cases

497

576

729

924

Persons

23,997

24,000

24,001

23,998

Person-years

297,098

295,908

294,857

292,552

HF incidence ¹

1.67(1.53–1.83)

1.95(1.79–2.11)

2.47(2.30–2.66)

3.16(2.96–3.37)

Model 1 ²

1

1.16(1.03–1.31)

1.48(1.32–1.66)

1.90(1.70–2.11)

< 0.001

1.44(1.37–1.51)

< 0.001

Model 2 ³

1

1.12(1.00-1.27)

1.41(1.26–1.58)

1.90(1.70–2.12)

< 0.001

1.47(1.40–1.55)

< 0.001

Model 3 ⁴

1

1.00(0.88–1.12)

1.12(1.00-1.26)

1.23(1.09–1.39)

< 0.001

1.17(1.10–1.24)

< 0.001

Sensitivity analysis

Sensitivity analysis 1 ⁵

1

1.00(0.88–1.13)

1.14(1.01–1.28)

1.23(1.10–1.41)

< 0.001

1.18(1.10–1.25)

< 0.001

Sensitivity analysis 2 ⁶

1

0.97(0.84–1.11)

1.11(0.98–1.27)

1.17(1.02–1.34)

0.006

1.13(1.06–1.22)

< 0.001

Competing risk regression ⁷

1

1.01(0.90–1.14)

1.14(1.02–1.29)

1.25(1.10–1.41)

< 0.001

1.18(1.10–1.25)

< 0.001